Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone.

Keiichi Tominaga ¹, Masakazu Nakano, Mina Hoshino, Kazunari Kanke, Hideyuki Hiraishi, BMC Gastroenterol. 2013 Mar 1;13:41.

In appropriately selected patients, GMA has significant efficacy with no safety concern. The higher cost of GMA vs PSL should be compromised by good safety profile of this non-pharmacological treatment intervention.

https://pubmed.ncbi.nlm.nih.gov/23452668/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599731/pdf/1471-230X-13-41.pdf